Call for Papers: Inaugural Issue of QES MedPharm Journal

2026-09-20

Call for Papers: Inaugural Issue

QES MedPharm Journal is pleased to invite submissions for its Inaugural Issue, Volume 1, Issue 1.

Published by QES Academic Press, a scholarly publishing imprint of Quest Educational Services (Private) Limited, Pakistan, QES MedPharm Journal aims to provide a professional platform for the dissemination of rigorous, ethical, transparent, and scientifically relevant research in medical, pharmaceutical, biomedical, and allied sciences.

We welcome high-quality manuscripts from researchers, clinicians, academicians, postgraduate scholars, and research groups worldwide.

Areas of interest include, but are not limited to:

  • Pharmacology and clinical pharmacology
  • Pharmaceutical sciences and drug development
  • Pharmacokinetics and pharmacodynamics
  • Toxicology and drug safety
  • Pharmacovigilance and pharmacoepidemiology
  • Experimental and translational pharmacology
  • Medicinal plants and natural products
  • Molecular and cellular pharmacology
  • Drug discovery and medicinal chemistry
  • Bioinformatics and computational pharmacology
  • Network pharmacology and systems pharmacology
  • Molecular docking, molecular dynamics, and ADMET studies
  • Artificial intelligence in drug discovery
  • Public-dataset and secondary-data research
  • Genomics, transcriptomics, and biomarker studies
  • Clinical therapeutics
  • Precision and personalized medicine
  • Pharmaceutical biotechnology
  • Systematic reviews and meta-analyses
  • Evidence-based medicine and related biomedical research

Manuscript types considered

Original Research Articles
Review Articles
Systematic Reviews and Meta-analyses
Short Communications
Methodological Articles
Computational and In Silico Studies
Public-Dataset and Bioinformatics Studies
Clinical and Observational Research

All submitted manuscripts will undergo editorial assessment and independent peer review in accordance with the journal's editorial and publication ethics policies.

Computational and in silico studies should demonstrate a clear scientific rationale, methodological rigor, reproducibility, novelty, and appropriate validation. Studies based solely on routine molecular docking without sufficient scientific depth or validation may not be considered suitable.

Similarly, studies based on publicly available datasets are welcome when they present a clearly defined research question, appropriate statistical methodology, reproducible analysis, and meaningful scientific interpretation.

Why submit to the inaugural issue?

Authors publishing in the inaugural issue will contribute to establishing the scientific foundation and academic identity of QES MedPharm Journal. Published articles will receive professional editorial processing, individual article webpages, and professionally formatted publication files in accordance with journal policies.

Submission Deadline: 10 November 2026

Expected Publication: January 2027

Submit your manuscript:
Please use the Make a Submission / New Submission option available on the QES MedPharm Journal website.

Journal website:
qesmedpharm.com

Publisher:
QES Academic Press
A Scholarly Publishing Imprint of Quest Educational Services (Private) Limited), Pakistan

We warmly invite the international research community to contribute to the Inaugural Issue of QES MedPharm Journal.

QES MedPharm Journal
Advancing Research in Medical, Pharmaceutical and Biomedical Sciences